Effect of Moderate Hypothermia on Systemic and Internal Jugular Plasma IL-6 Levels After Traumatic Brain Injury in Humans
- 1 March 1999
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 16 (3), 225-232
- https://doi.org/10.1089/neu.1999.16.225
Abstract
Moderate hypothermia may reduce subsequent neuronal damage after traumatic brain injury. Interleukin (IL)–6 may have a role in the pathogenesis of traumatic neuronal damage or repair. Using the enzyme-linked immunological sorbent assay (ELISA), we serially measured IL-6 levels in plasma obtained from the radial artery (systemic) and internal jugular vein (regional) in 13 cerebral trauma patients who underwent hypothermia of 32–33°C ranged from 4–9 days postinjury and 10 head-injured patients who were maintained at normothermic levels (36–37°C). In both patient populations, surface cooling was used since even in the normothermic group, cooling was needed to maintain patient temperature in the normothermic range. All patients were mechanically ventilated after injection of midazolam and vecuronium. The administration of these agents were continued until the end of the study. Hypothermia was typically maintained for four days, however, in some cases based upon CT findings and/or intra-cranial pressure change, the duration was prolonged. No significant differences were found between the two groups in age, gender and Glasgow Coma Scale upon admission. Further, no differences were found in terms of the classification of computed tomography findings or the occurrence of pupillary abnormalities on admission. The patients in this study had not sustained either abdominal or thoracic trauma. Before inducing hypothermia, IL-6 levels in the arterial and internal jugular venous blood exceeded the normal range. Specifically, the internal jugular plasma levels were significantly higher than those in the arterial plasma. While IL-6 levels in the normothermic group did not decrease even at 4 days postinjury, the plasma cytokine levels fell at both sites sharply after moderate hypothermia. The cytokine suppression found in the hypothermic group continued even after rewarming in these patients showing an improved clinical course, but not in those whose condition worsened. In addition to these changes in cytokine levels, the Glasgow Outcome Scale at 6 months postinjury was significantly higher in the hypothermic group than in the normothermia group. Based on the above, this clinical study with its small patient sample size suggests the need for further prospective randomized studies to examine the role of cytokine suppression in the beneficial effects of moderate hypothermia in patients with traumatic brain injury.Keywords
This publication has 25 references indexed in Scilit:
- Magnetic resonance imaging—monitored acute blood-brain barrier changes in experimental traumatic brain injuryJournal of Neurosurgery, 1996
- Moderate hypothermia in patients with severe head injury: cerebral and extracerebral effectsJournal of Neurosurgery, 1996
- Reactive Astrocytes in Acute Stage after Experimental Brain Injury: Relationship to Extravasated Plasma Protein and Expression of Heat Shock ProteinJournal of Neurotrauma, 1996
- The influence of cytokines on the integrity of the blood-brain barrier in vitroJournal of Neuroimmunology, 1996
- INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIESShock, 1995
- The Blood–Brain Barrier Disruption to Circulating Proteins in the Early Period after Fluid Percussion Brain Injury in RatsJournal of Neurotrauma, 1995
- Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Stroke, 1992
- Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operationClinical Immunology and Immunopathology, 1989
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Disability after severe head injury: observations on the use of the Glasgow Outcome Scale.Journal of Neurology, Neurosurgery & Psychiatry, 1981